Welcome to our dedicated page for Restart Life news (Ticker: NMLSF), a resource for investors and traders seeking the latest updates and insights on Restart Life stock.
Restart Life Sciences Corp. reports developments in its better-for-you functional food and consumer packaged goods portfolio. The company operates through Holy Crap Foods Inc., a wholly owned subsidiary focused on superseed cereals, oatmeal and related gut-health products, and also references wellness product lines such as BrainQ™ and BrainBalls™ for cognitive health.
Recurring updates cover Holy Crap Foods integration, wholesale and e-commerce sales channels, Amazon Canada and Walmart.ca distribution, certified manufacturing capabilities, product development with the University of Manitoba’s Richardson Centre for Food Technology and Research, and internal infrastructure for brand scaling. Company news also includes board appointments, capital-markets oversight, related-party share issuance disclosures and broader operational execution across its functional wellness platform.
Restart Life Sciences (OTC Pink: NMLSF) announced that wholly owned subsidiary Holy Crap Foods secured a listing on Walmart Canada’s online marketplace, Walmart.ca, with initial Superseed and Oatmeal Variety Pack inventory in transit to Walmart’s fulfillment network.
The company expects product availability after receipt and system activation and plans to expand SKUs on Walmart.ca based on sales data and customer demand to broaden distribution and e-commerce reach across Canada.
Restart Life Sciences (OTC Pink: NMLSF) announced that its wholly owned subsidiary Holy Crap Foods surpassed 500,000 units sold from January 2023 through March 2026. The release annualizes this to ~165,000+ units/year and cites growing repeat purchases, Canadian concentration, and early expansion into the United States and Caribbean.
The company says production capacity is in place to scale, and management intends to grow distribution, brand awareness, and its functional-wellness platform including BrainQ and BrainBalls.
Restart Life Sciences (OTC: NMLSF) completed the acquisition of Holy Crap Foods on Feb 27, 2026 and reported first full 30-day operational results for March 2026. Management implemented distribution realignment, marketing investments, and operational efficiencies to support scalable growth.
Key March metrics: direct wholesale $57,281, total wholesale $101,884, ecommerce $24,464 (Amazon Canada $11,058), total brand sales $126,348, and 18,937 units sold.
Restart Life Sciences (OTC Pink: NMLSF) highlighted its Holy Crap certified manufacturing platform on March 11, 2026, citing Organic, Kosher, Non-GMO, SQF, Safe Food for Canadians licence and FDA registration. The facility supports margin expansion, reduced co-packing reliance, broader retail and export distribution, and a University of Manitoba collaboration for ingredient validation. The company also granted 1,000,000 RSUs to consultants under its existing plan.
Restart Life Sciences (OTC Pink: NMLSF) announced a research collaboration with the University of Manitoba Richardson Centre for Food Technology and Research on March 3, 2026, following its acquisition of Holy Crap Foods.
The program will support formulation validation, ingredient functionality, bioavailability assessment, stability testing, and technical recommendations across BrainQ™, BrainBalls™, Holy Crap™ and future functional foods.
Restart Life Sciences (OTC: NMLSF) closed its acquisition of Holy Crap Foods effective February 27, 2026, adding in excess of $1 million in annualized revenue and making Restart Life a revenue-producing company.
The deal transfers Holy Crap's full brand portfolio, IP, customer and supplier contracts, inventory, and a turnkey manufacturing facility in Gibsons, BC, enabling immediate operational continuity and reduced near-term capital expenditure while supporting the company's growth plans in health and wellness.
Restart Life Sciences (OTC Pink: NMLSF) entered a Definitive Agreement dated February 12, 2026 to acquire 100% of Holy Crap Foods for $1,000,000 cash, subject to customary working capital adjustments.
Closing is anticipated within ten business days pending customary conditions; Holy Crap will operate as a wholly owned subsidiary and includes a British Columbia manufacturing facility.
Restart Life Sciences (OTC Pink: NMLSF) received aggregate gross proceeds of approximately CAD$590,000 on December 22, 2025 from warrant exercises and a corporate loan.
Holders exercised 4,103,023 warrants for about CAD$340,000, including the CEO's exercise of 1,303,023 warrants for roughly CAD$130,000. The company also closed a CAD$250,000 arm's-length loan at 12% annual interest, payable monthly, with a 12-month term and renewal option.
Net proceeds are intended to advance a binding LOI dated December 22, 2025 to acquire 100% of Holy Crap Foods from Happy Belly Food Group (CSE: HBFG), support planned Food Studies, and for general working capital; closing remains subject to due diligence, definitive agreements and regulatory approvals including CSE approval.
Restart Life Sciences (OTC Pink: NMLSF) signed a binding LOI dated December 21, 2025 to acquire 100% of Holy Crap Foods from Happy Belly Food Group for a CAD$1,000,000 purchase price subject to working capital adjustments.
Restart paid a CAD$100,000 deposit (10% of the price). The transaction includes the Holy Crap brand portfolio and a British Columbia co-packer facility to produce Restart's Brain Balls and other lines. The parties expect closing in early 2026, subject to Canadian Securities Exchange approval, with a business acquisition report due within 75 days of closing. Post-closing payment adjustments may be made within 12 months and will be secured against Holy Crap assets.
Restart Life Sciences (OTC: NMLSF) closed an over-subscribed second tranche of a non-brokered private placement on December 18, 2025, raising gross proceeds of CDN$630,000 in the tranche and CDN$1,130,000 in total across two tranches.
The company issued 6,300,000 units at CDN$0.10 per unit; each unit includes one common share and one transferable warrant exercisable for one year at CDN$0.10. The company also issued 132,000 non-transferable finder warrants exercisable for one year at CDN$0.10. Proceeds are earmarked for health food trials, potential acquisitions, and general working capital. Securities are subject to a four-month-and-one-day hold expiring April 18, 2026.